Back to Search Start Over

Cannabis smoking impairs drivingperformance on the simulator and realdriving: a randomized, double-blind,placebo-controlled, crossover trial

Authors :
Jacques Taillard
Julien Dupouey
Elisabeth Jouve
Daniel Mestre
Colas N. Authié
Bruno Lacarelle
Romain Truillet
Olivier Rascol
Joëlle Micallef
Olivier Blin
Agnès Daurat
Pierre Philip
Euromov (EuroMov)
Université de Montpellier (UM)
Service de Pharmacologie Clinique [Hôpital de la Timone - APHM]
Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)
Centre d'Investigation Clinique [Hôpital de la Conception - APHM] (CIC)
Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Institut Paoli-Calmettes
Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION)
Clinical Pharmacokinetics
Hôpital de la Timone [CHU - APHM] (TIMONE)
Laboratoire Mouvement Adaptation Cognition (MAC)
Université Bordeaux Segalen - Bordeaux 2-Centre National de la Recherche Scientifique (CNRS)
Cognition, Langues, Langage, Ergonomie (CLLE-LTC)
École pratique des hautes études (EPHE)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Toulouse - Jean Jaurès (UT2J)-Centre National de la Recherche Scientifique (CNRS)
Institut de la Vision
Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC)
Clinical Investigation Centre (CIC-UPCET) and Department of Clinical Pharmacology
Centre investigation clinique - Unité de pharmacologie clinique et d'évaluations thérapeutiques (CIC-UPCET)
Assistance Publique - Hôpitaux de Marseille (APHM)-Assistance Publique - Hôpitaux de Marseille (APHM)
Centre d'investigation clinique de Toulouse (CIC 1436)
Université Toulouse III - Paul Sabatier (UT3)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Sommeil, Attention et Neuropsychiatrie [Bordeaux] (SANPSY)
Université de Bordeaux (UB)-CHU de Bordeaux Pellegrin [Bordeaux]-Centre National de la Recherche Scientifique (CNRS)
Institut des Sciences du Mouvement Etienne Jules Marey (ISM)
Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)
École Pratique des Hautes Études (EPHE)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Toulouse - Jean Jaurès (UT2J)
Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)
Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Pôle Santé publique et médecine publique [CHU Toulouse]
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Sommeil, Addiction et Neuropsychiatrie [Bordeaux] (SANPSY)
Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)
Source :
Fundamental and Clinical Pharmacology, Fundamental and Clinical Pharmacology, Wiley, 2018, ⟨10.1111/fcp.12382⟩, Fundamental and Clinical Pharmacology, Wiley, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩, Fundamental & Clinical Pharmacology, Fundamental & Clinical Pharmacology, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

Driving experiments in real conditions are considered as a 'gold standard' to evaluate the effects of drugs on driving performance. Several constraints are difficult to manage in these conditions, so driving simulation appears as the best alternative. A preliminary comparison is crucial before being able to use driving simulation as a valid evaluation method. The aim of this study was to design a driving simulation method for assessing drug effects on driving. We used cannabis (THC) as a positive control and assessed whether THC affects driving performance in simulation conditions and whether these effects are consistent with performance in real driving conditions. A double-blind, placebo-controlled, two successive two-way crossover design was performed using cigarettes containing 20 mg of THC. Healthy occasional users of THC, aged 25-35 years, who had a consistent driving experience were included. The first two sessions were realized in simulation conditions, and the last two sessions were in real driving conditions. Driving performance was estimated through inappropriate line crossings (ILC) and the standard deviation of the vehicle's lateral position. Participants felt significantly drowsier and more tired after THC, whatever the driving condition. Driving stability was significantly impaired after THC, both in simulated and real driving conditions. We also found that ILC were significantly more numerous in driving simulation conditions, as compared to real driving. In conclusion, the driving simulator was proven to be more sensitive for demonstrating THC-induced effects on driving performances. Driving simulation appears to be a good qualitative predictor of driving safety after drug intake.

Details

Language :
English
ISSN :
07673981 and 14728206
Database :
OpenAIRE
Journal :
Fundamental and Clinical Pharmacology, Fundamental and Clinical Pharmacology, Wiley, 2018, ⟨10.1111/fcp.12382⟩, Fundamental and Clinical Pharmacology, Wiley, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩, Fundamental & Clinical Pharmacology, Fundamental & Clinical Pharmacology, 2018, 32 (5), pp.558-570. ⟨10.1111/fcp.12382⟩
Accession number :
edsair.doi.dedup.....5397c779283dfb6ee700f316ce2bbea3